MedTrace Logo

Preventing Exercise Resistance With Sedentary Interruptions

NCT06277713 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 24

Last updated 2024-03-04

No results posted yet for this study

Summary

The goal of this randomised cross-over trial is to learn about the interaction between sedentary behaviour throughout the day and the metabolic effect of an exercise bout on that same day in office workers with an increased risk for chronic disease.

The main question this study aims to answer is if the lipid-lowering effects of an exercise bout can be more pronounced by implementing alternations between a seated and a standing working position throughout the day.

Participants will be asked to:

* Complete three intervention periods for a duration of 2 days at their workplace,
* Attend a supervised training session (60min) at the research facility at the end of each intervention period,
* Attend three assessment days at the research facility where postprandial metabolism will be evaluated after a standardised meal test.

Conditions

  • Sedentary Behavior
  • Lipid Metabolism Disorder
  • Exercise

Interventions

BEHAVIORAL

Standing interruptions

A mobile sit-to-stand desk will be installed at the workplace and participants are instructed to alternate their working position every 30 minutes during two working days (8h).

BEHAVIORAL

Exercise bout

Participants will perform a continuous aerobic exercise bout for a duration of 60 minutes at a moderate intensity, which is defined as 60% of their maximal oxygen uptake (VO2max).

BEHAVIORAL

Sedentary

Participants are instructed to minimise any behaviour that is not sedentary during two working days (8h).

Sponsors & Collaborators

  • Hasselt University

    lead OTHER

Principal Investigators

  • Bert Op 't Eijnde, Prof. dr. · Hasselt University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
30 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-02-19
Primary Completion
2024-10-30
Completion
2025-07-01

Countries

  • Belgium

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06277713 on ClinicalTrials.gov